In the last years, the amount of available data in the field of computational biology steadily increased. In order to be able to analyze these data, various algorithms have been developed by bioinformaticians to process them efficiently. Moreover, computational models were developed to predict for instance biological relationships of species. Furthermore, the prediction of properties like the structure of certain biological molecules is modeled by complex algorithms. Despite these advances in handling such complicated tasks with automated workflows and a huge variety of freely available tools, the expert still needs to supervise the data analysis pipeline inspecting the quality of both the input data and the results. Additionally, choosing appropriate parameters of a model is quite involved. Visual support puts the expert into the data analysis loop by providing visual encodings of the data and the analysis results together with interaction facilities. In order to meet the requirements of the experts, the visualizations usually have to be adapted for the application purpose or completely new representations have to be developed. Furthermore, it is necessary to combine these visualizations with the algorithms of the experts to prepare the data. These in-situ visualizations are needed due to the amount of data handled within the analysis pipeline in this domain. In this thesis, algorithms and visualizations are presented that were developed in two different research areas of computational biology. On the one hand, the multi-replicate peak-caller Sierra Platinum was developed, which is capable of predicting significant regions of histone modifications occurring in genomes based on experimentally generated input data. This algorithm can use several input data sets simultaneously to calculate statistically meaningful results. Multiple quality measurements and visualizations were integrated into to the data analysis pipeline to support the analyst. Based on these in-situ visualizations, the analyst can modify the parameters of the algorithm to obtain the best results for a given input data set. Furthermore, Sierra Platinum and related algorithms were benchmarked against an artificial data set to evaluate the performance under specific conditions of the input data set, e.g., low read quality or undersequenced data. It turned out that Sierra Platinum achieved the best results in every test scenario. Additionally, the performance of Sierra Platinum was evaluated with experimental data confirming existing knowledge. It should be noticed that the results of the other algorithms seemed to contradict this knowledge. On the other hand, this thesis describes two new visualizations for RNA secondary structures. First, the interactive dot plot viewer iDotter is described that is able to visualize RNA secondary structure predictions as a web service. Several interaction techniques were implemented that support the analyst exploring RNA secondary structure dot plots. iDotter provides an API to share or archive annotated dot plots. Additionally, the API enables the embedding of iDotter in existing data analysis pipelines. Second, the algorithm RNApuzzler is presented that generates (outer-)planar graph drawings for all RNA secondary structure predictions. Previously presented algorithms failed in always producing crossing-free graphs. First, several drawing constraints were derived from the literature. Based on these, the algorithm RNAturtle was developed that did not always produced planar drawings. Therefore, some drawing constraints were relaxed and additional drawing constraints were established. Building on these modified constraints, RNApuzzler was developed. It takes the drawing generated by RNAturtle as an input and resolves the possible intersections of the graph. Due to the resolving mechanism, modified loops can become very large during the intersection resolving step. Therefore, an optimization was developed. During a post-processing step the radii of the heavily modified loops are reduced to a minimum. Based on the constraints and the intersection resolving mechanism, it can be shown that RNApuzzler is able to produce planar drawings for any RNA secondary structure. Finally, the results of RNApuzzler are compared to other algorithms.

No description available.

When a species is introduced outside their native range, the genetic diversity of the introduced population is generally decreased due to the founder effect, and the fitness of individuals in the introduced population may decrease due to inbreeding depression. Invasive species are a paradox to this paradigm because while the initial population size of an invasive species may be small in their non-native range, the individuals are able to survive, eat, and reproduce so successfully, that they have deleterious effects on native species. One mechanism that invasive species use to overcome a lack of genetic diversity and adapt to their new environment is CpG methylation, a heritable and environmentally influenced epigenetic modification that regulates the expression of certain genes to alter phenotypes without altering an organism’s DNA sequence.Bighead and silver carps, two species of bigheaded carp native to eastern Asia, are believed to have been introduced to the United States in the 1970s. Since that time, populations of both bighead and silver carp have surged, particularly in the Mississippi River drainage, where they compete with native planktivores for food, injure boaters, and threaten the multi-million dollar fisheries industry in the Great Lakes. In this study, methylation-sensitive amplified fragment length polymorphisms (MS-AFLPs) were used to analyze the genetic and epigenetic diversity of bighead and silver carp from the Gan, Pearl, and Yangtze rivers in their native China and from the Illinois River in the United States. While the heterozygosity of silver carp in Illinois was not found to be significantly lower than that of silver carp in China, the silver carp in Illinois did show a significantly higher level of methylation compared to Chinese silver carp. There is evidence that CpG methylation may play a significant role in allowing silver carp to adapt and thrive in an introduced environment.

<p>Epigenetic mechanisms, including DNA methylation, play an important role in regulation of stem cell fate and tumorigenesis. The Ten-Eleven-Translocation 2 (TET2) is a core enzyme for DNA demethylation by catalyzing the conversion of 5-methylcytosine (5mC) to 5-hydromethylcytosine (5hmC). It has been shown that TET2 is the main regulator of hematopoietic stem cell homeostasis and loss of TET2 is highly associated with hematopoietic malignancies. Our previous work has also shown that loss of TET2 expression is linked to promotion of an epithelial-mesenchymal-transition phenotype and expansion of a breast cancer stem cell-like population with skewed asymmetric cell division in vitro; however, the in vivo role that TET2 plays in regulation of mammary stem cell (MaSC) fate and development of mammary pathology has yet to be determined. Here, using our newly established mammary-specific Tet2-knockout mouse model, the data reveals for the first time that TET2 plays a pivotal role in mammary gland development via directing MaSC to luminal lineage commitment in vivo. Furthermore, we find that TET2 coordinates with FOXP1 to target and demethylate FOXA1, GATA3, and ESR1, key transcription factors that orchestrate mammary luminal lineage specification and endocrine response and are often silenced by DNA methylation in aggressive human breast cancers. Finally, loss of TET2 expression leads to promotion of mammary tumor development with defective luminal cell differentiation and tamoxifen resistance in a PyMT;Tet2 deletion breast cancer mouse model. As a result, this study provides a previously unidentified role for TET2 in governing luminal lineage specification and endocrine response that underlies resistance to anti-estrogen treatments.</p>

La tumeur de Wilms est la tumeur du rein la plus courante chez les enfants. Actuellement, près de 80 % à 90 % des patients survivent, mais quelques patients ne répondront pas aux traitements ou auront une rechute. L’objectif de ce projet est de caractériser la nouvelle mutation P904L dans le gène DNMT3A retrouvée chez un patient atteint de la tumeur de Wilms qui était en rechute. L’impact de cette nouvelle mutation est encore inconnu, mais des mutations dans le gène de DNMT3A sont fréquemment retrouvées dans le cancer. Le contexte de la mutation dans le patient et sa récurrence dans d’autres cancers et syndrome nous portent à croire que cette mutation affecte la fonction de DNMT3A. La perte de fonction de DNMT3A ainsi que certains de ses mutants sont connus pour altérer des caractéristiques du cancer comme la différenciation et l’immortalisation des cellules. On sait aussi que les tumeurs de Wilms ont des cellules qui gardent un aspect non différencié ou embryonnaire. Nous supposons que l’impact de la mutation P904L sur DNMT3A contribue au développement de la tumeur de Wilms. Pour démontrer l’impact de cette nouvelle mutation sur la protéine et sur le développement tumoral, nous avons utilisé à la fois des tests fonctionnels classiques et le séquençage de nouvelle génération. Puisque DNMT3A est un gène qui affecte la méthylation de l’ADN et régule l’expression, nous avons évalué le profil d’expression de la mutation P904L pour voir son impact sur la fonction du gène DNMT3A. Nos travaux démontrent que la nouvelle mutation P904L cause une perte de fonction de l’enzyme DNMT3A. Cette mutation altère le renouvellement cellulaire et la migration en plus de moduler la réponse à des agents thérapeutiques. Nous avons aussi constaté que la mutation module l’expression génique et que cette modulation est cohérente avec le profil d’expression du patient. En conclusion, nous suggérons trois mécanismes par lesquels le mutant contribue à la progression et au développement de la tumeur de Wilms. Nous démontrons aussi la nécessité d’approfondir nos connaissances sur cette tumeur afin de pouvoir proposer de nouvelles options thérapeutiques aux patients en rechute ou qui ne répondent pas aux traitements classiques. / Wilms tumours are the most common kidney tumour in children. As of now, almost 80 % to 90 % of the patients survive but there is still some who do not respond. This project objective is to study the novel mutation P904L in the DNMT3A gene discovered in a relapse Wilms tumour’s patient. The impact of this variant is unknown, but mutations in DNMT3A are frequently found in cancer. The context of the mutation in the patient and the recurrence of this mutation in other cancers and syndrome make us believe that it is affecting the function of the DNMT3A protein. Loss of function and some mutations of DNMT3A are known to affect crucial characteristics of cancers such as differentiation and immortalization. It is also known that Wilms tumours are made of undifferentiated or embryonic looking cells. We supposed that the impact of the mutation on DNMT3A protein contribute to the development of the tumour. To prove that this new mutation is affecting the protein and the development of the tumour, we used both functional assays and next generation sequencing technologies. Because DNMT3A is a gene affecting the methylation of the DNA and thus regulating gene expression, we used expression profile to assess the impact of the mutation on the enzyme DNMT3A. We demonstrate that the new mutation P904L causes a loss of function of the DNMT3A protein. This mutation affects the self-renew and the migration of the cells. Moreover, it modulates the response to drugs. We also found that the mutation modulates the gene expression in the cell line and this modulation is coherent with the expression pattern of the patient. In conclusion, we suggest three mechanisms by which this new mutant contributes to the development and progression of Wilms tumours. We also show that there is a need to further our knowledge of this tumour in order to propose new therapeutics options to non-responsive patient.

(eng) The phenomenon of hybrid sterility represents one of the evolutionary mechanisms that enables speciation. Only a few speciation genes have been uncovered. The only one found in mammals is Prdm9 (PR-domain 9). Data in the literature on the involvement of Prdm9 in decreased fertility of various semifertile hybrid males of house mouse subspecies were scarce before the results of this thesis were completed, despite that such males are much more frequent in nature than the fully sterile ones. Utilizing a panel of genetic tools and a battery of phenotyping tests, this thesis shows a central role of Prdm9 in fecundity of hybrids, including many fertility disorders and age dependency. Both increasing and reducing the Prdm9 gene dosage significantly elevated fertility parameters. Surprisingly, even the allele that in one copy causes full hybrid sterility increased F1 hybrid fertility when present in multiple copies. The PRDM9 protein also plays a role in identifying the sites of meiotic recombination. This study also points out the principles of allelic competition in determination of the sites of preferred recombination (hotspots), which suggests a possible link between both previously described Prdm9 roles. This thesis summarizes a set of three logically interconnected publications with the ambition...

The sex-dependent pituitary growth hormone (GH) secretory profiles, pulsatile in males and persistent in females, regulate sex-biased expression of hundreds of genes in mammalian liver, contributing to sex differences in hepatic metabolism and disease. The sex-biased GH actions in the liver are mediated by STAT5b and enhanced by a network of transcription factors including the male-biased BCL6 and the female-specific CUX2, acting in the context of sex-biased chromatin states. First, the transcriptional and epigenomic changes induced by continuous-GH infusion (cGH) in male mice, which rapidly feminizes the temporal profile of liver STAT5 activity, were examined. RNA-seq analysis determined that cGH repressed the majority of male-biased genes and induced most female-biased genes within 4-days; however, several highly female-specific genes showed partial feminization. Female-biased genes already in an active chromatin state in male liver were induced early; genes in an inactive chromatin state often responded late. Early cGH-responsive genes included Cux2 and Bcl6 and their targets. DNase-seq and ChIP-seq were used to identify changes in sex-specific chromatin accessibility and histone modifications accompanying these cGH-induced gene expression changes. H3-K27me3 is a key sex-biased repressive mark found preferentially at highly female-biased genes in male mouse liver. Consistently, induction of female-biased genes by cGH was associated with loss of H3-K27me3 at their gene bodies. H3K27 methylation is catalyzed by Polycomb Repressive Complex-2 (PRC2) through its homologous catalytic subunits EZH1 and EZH2. An Ezh1-knockout mouse model with a hepatocyte-specific knockout of Ezh2 (DKO) was used to further investigate the role of H3-K27me3 in repressing sex-biased genes in mouse liver. Loss of Ezh1/Ezh2 led to a significant decrease in sex-specific gene expression, with many female-biased genes induced and male-biased genes repressed. These gene responses were more extensive in male than female liver, as was the loss of H3K27me3 sites and the reciprocal increases in active histone marks. There was substantial up-regulation of liver cancer and liver fibrosis-related genes in male and female DKO-mouse liver, with a subset of genes preferentially up-regulated in females. Thus, GH regulated sex-biased liver physiology is dictated by transcription factors arranged in a hierarchical network and by dynamic sex-biased epigenetic states. / 2020-06-12T00:00:00Z

<p>RNA-directed DNA methylation (RdDM) is a process by which epigenetic silencing is maintained at the boundary between genes and flanking transposable elements. In maize, RdDM is dependent on <i>Mediator of Paramutation 1 (Mop1</i>), a putative RNA dependent RNA polymerase. Here I show that although RdDM is essential for the maintenance of DNA methylation of a silenced <i>MuDR</i> transposon in maize, a loss of that methylation does not result in a restoration of activity of that element. Instead, heritable maintenance of silencing is maintained by histone modifications. At one terminal inverted repeat (TIR) of the element, heritable silencing is mediated via H3K9 and H3K27 dimethylation, even in the absence of DNA methylation. At the second TIR, heritable silencing is mediated by H3K27 trimethylation, a mark normally associated with somatically inherited gene silencing. I find that a brief exposure of high temperature in a <i>mop1</i> mutant rapidly reverses both of these modifications in conjunction with a loss of transcriptional silencing. These reversals are heritable, even in <i>mop1</i> wild type progeny in which methylation is restored at both TIRs. These observations suggest that DNA methylation is neither necessary to maintain silencing, nor is it sufficient to initiate silencing once it has been reversed. To leverage the specificity of our observations made at bench, I also performed a transcriptome analysis in <i>mop1</i> mutants under heat. I found that a substantial number of genes as well as a subset of TEs are reactivated in <i>mop1</i> mutants under heat, which is consistent with the effects I observed on <i>MuDR</i>. Interestingly, I found that <i>mop1</i>-specific reactivation of TEs is closely correlated with changes in expression of nearby genes, most of which are involved in metabolic transportation and sensing. This suggests that one function of <i>MOP1</i> is to prevent inappropriate expression of genes in this pathway when they are close to TEs. Taken together, my work will provide an opportunity to better understand the causes and consequences of TE silencing and reactivation, as well as the effects of TEs on gene regulation under stress conditions.</p>

Epigenetics, or alterations in the phenotype or gene expression due to mechanisms other than changes in the underlying DNA sequence, reflects the sensitivity and responsiveness of human and animal brains in constantly varying circumstances regulating gene expression profiles that define the biomarkers and present the ultimate phenotypical outcomes, such as cognition and emotion. Epigenetics is associated with functionally relevant alterations to the genome in such a fashion that under the particular conditions of early, adolescent, and adult life, environmental signals may activate intracellular pathways that remodel the "epigenome," triggering changes in gene expression and neural function. Thus, genetic influences in neuropsychiatric disorders that are subject to clinical staging, epigenetics in schizophrenia, epigenetic considerations in the expression of sensorimotor gating resulting from disease conditions, biomarkers of drug use and addiction, current notions on the role of dopamine in schizophrenia spectrum disorders, and the discrete interactions of biomarkers in persistent memory were to greater or lesser extents reflected upon. The relative contributions of endophenotypes and epistasis for mediating epigenetic phenomena and the outcomes as observed in the analysis of biomarkers appear to offer a multitude of interactive combinations to further complicate the labyrinthine machinations of diagnosis, intervention, and prognosis.

Sepsis-induced myeloid-derived suppressor cells (MDSCs) increase mortality risk. We previously identified that long non-coding RNA Hotairm1 supports myeloid precursor shifts to Gr1+CD11b+ MDSCs during mouse sepsis. A major unanswered question is what molecular processes control Hotairm1 expression. In this study, we found by a genetic deletion that a specific PU.1-binding site is indispensable in controlling Hotairm1 transcription. We then identified H3K4me3 and H3K27me3 at the PU.1 site on the Hotairm1 promoter. Controlling an epigenetic switch of Hotairm1 transcription by PU.1 was histone KDM6A demethylase for H3K27me3 that derepressed its transcription with possible contributions from Ezh2 methyltransferase for H3K27me3. KDM6A knockdown in MDSCs increased H3K27me3, decreased H3K4me3, and inhibited Hotairm1 transcription activation by PU.1. These results enlighten clinical translation research of PU.1 epigenetic regulation as a potential sepsis immune-checkpoint treatment site.